2025 annual financial data
Edesa Biotech 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -7,911,566 USD and net income was -7,185,523 USD.
Operating cash flow was -7,322,262 USD.
Get free Edesa Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,911,566 USD
- Net income
- -7,185,523 USD
- Operating cash flow
- -7,322,262 USD